MENLO PARK, Calif., Sept. 26, 2019 /PRNewswire/ -- Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, today announced that clinical results and a patient case involving its RheOxTM Bronchial Rheoplasty system will be presented at the 2019 ERS International Congress, occurring Sept. 28 - O

MUMBAI, India and WARREN, New Jersey, Sept. 26, 2019 /PRNewswire/ -- Cipla Limited and its subsidiary Cipla USA, Inc., (hereafter referred to as "Cipla") announce the launch of Daptomycin for Injection, 500mg/vial, single-dose vial, AP-rated generic equivalent of Cubicin® for Injection in

REHOVOT, Israel, Sept. 26, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced financial results for the second quarter ended June 30, 2019 and provided an update on the Company's business developments. Certain metrics, including those expressed on an adjusted basis, are non-GAAP meas

ROCKVILLE, Md., Sept. 26, 2019 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the mi

DES MOINES, Iowa., Sept. 26, 2019 /PRNewswire/ -- BioSpace, the leader in life sciences news and careers, today announced that Genentech, Pfizer, Merck, Amgen and Novartis landed in the top five spots of their latest Ideal Employer report.The Ideal Employer Report dives into the professional, demographic and attitudinal factors that determine who life science

FRANKLIN LAKES, N.J., Sept. 26, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Vincent A. Forlenza, chairman and CEO, will retire as CEO on Jan. 28, 2020, following the company's annual meeting of shareholders. Forlenza

NEW YORK, Sept. 26, 2019 /PRNewswire/ -- The Hereditary Neuropathy Foundation (HNF) is proud to share the Voice of the Patient (VoP) Report which was recently published on the FDA website. The report highlights the results of the Externally-led Patient-Focused Drug Development (PFDD) Meeting. This is a tremendous milestone for the CMT community - the US Food and Dru

PLEASANTON, Calif., Sept. 26, 2019 /PRNewswire/ -- Shaklee Corporation installed a Peace Pole, a prominent international symbol and monument to peace, at their global headquarters in Pleasanton, CA. A dedication ceremony took place on Thursday, September 19 to commemorate International Day of Peace and d

ST. LOUIS and TAMPA, Fla., Sept. 26, 2019 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene") and WellCare Health Plans, Inc. (NYSE: WCG) ("WellCare") announced today that, in connection with the previously announced merger agreement between Centene and WellCare, a subsidiary of WellCare has entered into a definitive ag

NEW YORK, Sept. 26, 2019 /PRNewswire/ -- 23andMe, the leading consumer genetics company, and TrialSpark, a technology company enabling physician practices to become clinical trial sites, are announcing a joint clinical trial offering that combines the power of 23andMe's crowdsourced research platform and extensive database of consenting customers with TrialSpark's distri